Chromocell Therapeutics Corp (CHRO)
NYSE MKT:CHRO
US Market
Holding CHRO?
Track your performance easily

Chromocell Therapeutics Corp (CHRO) Financial Statements

13 Followers

Chromocell Therapeutics Corp Financial Overview

Chromocell Therapeutics Corp's market cap is currently ―. The company's EPS TTM is $-1.684; its P/E ratio is -0.52; Chromocell Therapeutics Corp is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.77M----
EBITDA$ -1.77M----
Net Income Common Stockholders$ -1.77M$ -1.42M$ -953.35K$ -966.56K$ -739.59K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.45M$ 22.79K$ 81.89K$ 48.61K$ 55.07K
Total Assets$ 2.60M$ 22.79K$ 81.89K$ 48.61K$ 55.07K
Total Debt$ 1.59M$ 631.01K$ 540.16K$ 450.00K$ 435.63K
Net Debt$ -858.21K$ 608.22K$ 458.26K$ 401.39K$ 380.56K
Total Liabilities$ 2.79M$ 5.93M$ 4.98M$ 4.45M$ 3.76M
Stockholders Equity$ -182.52K$ -5.90M$ -4.90M$ -4.40M$ -3.71M
Cash Flow-
Free Cash Flow$ -2.95M$ -257.24K-$ -173.37K$ -666.62K
Operating Cash Flow$ -2.95M$ -257.24K-$ -173.37K$ -666.62K
Investing Cash Flow-----
Financing Cash Flow$ 1.59M$ 198.13K-$ 166.90K$ 548.45K
Currency in USD

Chromocell Therapeutics Corp Earnings and Revenue History

Chromocell Therapeutics Corp Debt to Assets

Chromocell Therapeutics Corp Cash Flow

Chromocell Therapeutics Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis